Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CID755673是一种高效选择性 PKD1抑制剂,IC50为182 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 498 | 现货 | ||
10 mg | ¥ 751 | 现货 | ||
25 mg | ¥ 1,232 | 现货 | ||
50 mg | ¥ 2,125 | 现货 | ||
100 mg | ¥ 3,798 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 548 | 现货 |
产品描述 | CID755673 is an effective and specific cell-active inhibitor for PKD (IC50: 182 nM); exhibits selective PKD1 inhibition when compared with PLK1, AKT, CAMKIIα, CAK, and PKC isoforms. |
靶点活性 | PKD:182 nM |
体外活性 | 在大鼠急性胰腺炎模型中,通过对PKD/ PKD1的抑制作用,CID755673可使坏死和胰腺炎的严重程度得到显著改善. |
体内活性 | 在HeLa细胞中,CID755673对PMA诱导的HDAC5核输出有显著阻断作用,且对PKD介导的蛋白质转运也有阻断作用。CID755673可直接抑制LNCaP前列腺癌细胞中PKD1的活性。CID755673有有效阻断前列腺癌细胞的迁移和侵入,并抑制肿瘤细胞增殖和细胞周期分布。 |
激酶实验 | In Vitro Radiometric PKD Kinase Assay: The radiometric kinase assay is carried out by coincubating 0.5 μCi of [γ-32P]ATP, 20 μM ATP, 50 ng of purified recombinant human PKD (PKD1, PKD2, and PKD3) or CAMKIIα proteins, and 2.5 μg of Syntide-2 in 50 μl of kinase buffer that contains 50 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 10 mM β-mercaptoethanol. The reaction is carried out under conditions that the initial rate is within the linear kinetic range. The filter papers are then washed three times in 0.5% phosphoric acid, air-dried, and counted using a Beckman LS6500 multipurpose scintillation counter. |
细胞实验 | Cell proliferation was determined by counting the number of viable cells upon trypan blue staining. Cell proliferation is measured by CellTiter-Glo Luminescent Cell Viability Assay according to the manufacturer's instructions.(Only for Reference) |
分子量 | 217.22 |
分子式 | C12H11NO3 |
CAS No. | 521937-07-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 21.7 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.6036 mL | 23.0181 mL | 46.0363 mL | 115.0907 mL |
5 mM | 0.9207 mL | 4.6036 mL | 9.2073 mL | 23.0181 mL | |
10 mM | 0.4604 mL | 2.3018 mL | 4.6036 mL | 11.5091 mL | |
20 mM | 0.2302 mL | 1.1509 mL | 2.3018 mL | 5.7545 mL | |
50 mM | 0.0921 mL | 0.4604 mL | 0.9207 mL | 2.3018 mL | |
100 mM | 0.046 mL | 0.2302 mL | 0.4604 mL | 1.1509 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CID755673 521937-07-5 Cell Cycle/Checkpoint Metabolism Serine/threonin kinase PKD Inhibitor Protein kinase D CID 755673 inhibit CID-755673 inhibitor